Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 8/20 | 1.00 |
| ▸ | AKR1C2 | P52895 | 5/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 9/20 | 0.84 |
| ▸ | CNR2 | P34972 | 2/20 | 0.84 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.69 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.69 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | PTGES | O14684 | 1/20 | 0.68 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.68 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.68 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30426824 | 0.91 | PTGS2 (1.00) | AKR1C3AKR1C2PTGS2CNR2MAPT | |
| SCHEMBL14086813 | 0.91 | PTGS2 (1.00) | AKR1C3AKR1C2PTGS2CNR2MAPT | |
| SCHEMBL30761037 | 0.91 | AKR1C3 (0.87) | AKR1C3AKR1C2PTGS2CNR2MAPT | |
| SCHEMBL13448804 | 0.91 | AKR1C3 (0.83) | AKR1C3AKR1C2PTGS2CNR2MAPT | |
| SCHEMBL15774085 | 0.90 | AKR1C3 (0.83) | AKR1C3AKR1C2PTGS2CNR2MAPT | |
| SCHEMBL2600801 | 0.90 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS2CNR2MAPT | |
| SCHEMBL6102416 | 0.89 | AKR1C3 (0.84) | AKR1C3AKR1C2PTGS2CNR2MAPT | |
| SCHEMBL17385243 | 0.89 | PTGS2 (0.84) | AKR1C3AKR1C2PTGS2CNR2MAPT | |
| SCHEMBL11458502 | 0.87 | AKR1C3 (0.80) | AKR1C3AKR1C2PTGS2CNR2MAPT | |
| SCHEMBL27768669 | 0.87 | AKR1C3 (0.78) | AKR1C3AKR1C2PTGS2CNR2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150141350-A1 | DENDRIMER BASED NANODEVICES FOR THERAPEUTIC AND IMAGING PURPOSES | Ashvattha Therapeutics, Inc. | 2015-05-21 | — | — | US | disclosed |
| US-9012647-B2 | Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2015-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141350-A1 | DENDRIMER BASED NANODEVICES FOR THERAPEUTIC AND IMAGING PURPOSES | PAM, MUC1, AADAC | AKR1C3 4052/4885AKR1C2 4294/4885PTGS2 1173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.